Cat.#: ACPP-1216
| Despition | PARD3 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1256 | Bestrophin Blocking Peptide (AC1256) | 250 µg | inquiry |
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1610 | Mouse MANF Protein (AC1610) | 5 µg | inquiry |
| ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg | inquiry |
| ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
| ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
| ACPP-1775 | Human SNPH Protein (AC1775) | 10 µg | inquiry |
| ACPP-1761 | Human VCAM1 Protein (AC1761) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.